(Q37427926)

English

Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

scientific article published on October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Rajesh Krishna

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Amit Garg

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Deborah Panebianco

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Josee Cote

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Arthur J Bergman

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Pascale Van Hoydonck

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Tine Laethem

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kristien Van Dyck

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jingjing Chen

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Cynthia Chavez-Eng

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Laura Archer

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ryan Lutz

12

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Deborah Hilliard

13

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Karen Snyder

14

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Bo Jin

15

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Luc Van Bortel

16

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kenneth C Lasseter

17

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nidal Al-Huniti

18

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kevin Dykstra

19

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Keith Gottesdiener

20

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

John A Wagner

21

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

1 October 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

68

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

535-545

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Residual risk in statin-treated patients: future therapeutic options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Effects of food on clinical pharmacokinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Drug treatment of lipid disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Plasma cholesteryl ester transfer protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

23 August 2017

Estimation of variance for harmonic mean half-lives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

26 June 2018

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

26 June 2018

Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

2 September 2018

Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

2 September 2018

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

2 September 2018

Development of a self-emulsifying formulation that reduces the food effect for torcetrapib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2780279

2 September 2018

Identifiers

10.1111/J.1365-2125.2009.03465.X

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37427926&oldid=2143934130"